Published in Blood Weekly, February 8th, 2007
Until recently, practitioners and their patients have had to deal with the uncertainty associated with complications due to procedure-related embolic events. For these patients, the evolving capabilities of embolic protection devices (EPD) have become an essential element in treatment decisions and therapeutic outcomes.
While the evolutionary success of embolic protection devises has been impressive, several...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.